Biorepository | CHOP Research Institute
 

Biorepository

This is a two-by-two factorial, response-adaptive multi-center randomized controlled clinical trial that tests whether pediatric patients with severe PARDS randomized to supine versus prone positioning and to CMV versus HFOV exhibit more VFD over a 28-day period.

Published on
Jun 24, 2024
The new CHOP Biobank has the potential to drive omics-based translational research, which can be transformative for pediatric healthcare.

Gastrointestinal motility disorders (GMD) and disorders of gut brain interactions (DGBI) include a wide spectrum of disease conditions, and it's relatively common in the general population.

The study will use residual blood collected from clinical samples collected around the time of meeting study inclusion to identify subphenotypes of subjects with shared underlying protein biomarker profiles, correlate subphenotypes with PICU morality, and assess degree of overlap between subphenotypes and classical syndromic definitions.

The LUng iNjury Group at Children's Hospital of Philadelphia is dedicated to advancing the care of children who have difficulty breathing, with a focus on hospitalized children with severe respiratory failure requiring mechanical ventilation.

Published on
Apr 14, 2023
Learn about a technique to analyze large datasets, preclinical results that show safety and efficacy of a drug that could help children with high-risk neuroblastoma, and a milestone in the CORSICA project that seeks to cure rare sinonasal cancers.

The goal of this study is to collect biological samples and medical information from children to create a Neuroscience Biorepository to advance future neurological research.

Collect data and blood samples to make observations and determinations about rate and severity of graft-versus-host disease in HCT patients.

This study involves the collection of medical information and samples from people with a confirmed or suspected leukodystrophy or related disorder affecting the white matter of the brain, as well as "healthy controls" who are not known to be affected by one of these disorders.

Healthy control children are needed to help participate in a study on Immunometabolic Dysregulation.